Ειδήσεις: ALLOGENE | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

01/04 11:30 statnews.com

STAT+: The biotech scorecard for the second quarter: 23 stock-moving events to watch

biotech STAT+Abivax Allogene Therapeutics obefazimod cema‑cel

29/03 23:46 yahoo.com

Why Allogene Therapeutics (ALLO) Says Its Lead Cancer Program Is Still on Track in 2026

Allogene Therapeutics cancer therapy 2026 preclinical data clinical trials regulatory strategy

26/03 19:55 statnews.com

Eli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buy

Eli Lilly Merck Terns CAR‑T biotech deals pharma acquisitions

26/03 19:28 statnews.com

STAT+: Denali Therapeutics, Corcept Therapeutics win FDA approvals

FDA approvals Denali Therapeutics Corcept Therapeutics Sarepta Allogene CAR‑T

26/03 12:31 statnews.com

STAT+: Allogene’s off-the-shelf CAR-T is nearing an early but pivotal study readout

Allogene Therapeutics CAR‑T off‑the‑shelf immunotherapy study readout investor confidence

26/03 12:31 statnews.com

STAT+: Allogene’s off-the-shelf CAR-T is nearing an early but pivotal study readout

Allogene Therapeutics CAR‑T off‑the‑shelf immunotherapy study readout investor confidence

Loading...